|
|
2009³âµµ Á¦ 95Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ ÃÖ¿ì¼ö³í¹®»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.
=== ´Ù À½ ===
ACCUVIX »ó
- ºÐ¾ß : ¸ðüžÆÀÇÇÐ
- ¼º¸í : ȲÇѼº (°Ç±¹ÀÇ´ë)
- Á¦¸ñ : Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction
- °ÔÀçÁö : American Journal of Obstetrics and Gynecology
ASTRAZENECA »ó
- ºÐ¾ß : »ý½Ä³»ºÐºñÇÐ
- ¼º¸í : Á¶½ÃÇö (¿¬¼¼ÀÇ´ë)
- Á¦¸ñ : Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis
- °ÔÀçÁö : Fertility & Sterility
Çѱ¹¿©¼º¾Ï¿¬±¸Àç´Ü »ó
- ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
- ¼º¸í : ³²ÀºÁö (¿¬¼¼ÀÇ´ë)
- Á¦¸ñ : MicroRNA expression profiles in serous ovarian carcinoma
- °ÔÀçÁö : Clinical Cancer Research
Bayer Schering Pharma »ó
- ºÐ¾ß : ÀϹݺÎÀΰúÇÐ
- ¼º¸í : Çѽ¼ö (Áß¾ÓÀÇ´ë)
- Á¦¸ñ : Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2
- °ÔÀçÁö : Human Reproduction
|
|
|
|
|